Drug Adherence and Long-Term Outcomes in Non-Revascularized Patients Following Acute Myocardial Infarction.

[1]  J. Ensor,et al.  Impact of Charlson Co-Morbidity Index Score on Management and Outcomes After Acute Coronary Syndrome. , 2020, The American journal of cardiology.

[2]  J. Ensor,et al.  Temporal Trends in Comorbidity Burden and Impact on Prognosis in Patients With Acute Coronary Syndrome Using the Elixhauser Comorbidity Index Score. , 2020, The American journal of cardiology.

[3]  M. Farkouh,et al.  Adherence to Statin Therapy Among US Adults Between 2007 and 2014 , 2019, Journal of the American Heart Association.

[4]  P. Armstrong,et al.  Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study. , 2018, International journal of cardiology.

[5]  B. D. de Mol,et al.  Predictors of medium-term mortality in patients hospitalised with coronary artery disease in a resource-limited South-East Asian setting , 2018, Open Heart.

[6]  Jennifer G. Robinson,et al.  Changes in Statin Adherence Following an Acute Myocardial Infarction Among Older Adults: Patient Predictors and the Association With Follow‐Up With Primary Care Providers and/or Cardiologists , 2017, Journal of the American Heart Association.

[7]  Jennifer G. Robinson,et al.  Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction. , 2017, Journal of the American College of Cardiology.

[8]  S. Pocock,et al.  Characteristics and outcomes of medically managed patients with non-ST-segment elevation acute coronary syndromes: Insights from the multinational EPICOR Asia study. , 2017, International journal of cardiology.

[9]  J. Ferrières,et al.  Editor’s Choice-Medically managed patients with non–ST-elevation acute myocardial infarction have heterogeneous outcomes, based on performance of angiography and extent of coronary artery disease , 2017, European heart journal. Acute cardiovascular care.

[10]  S. Halvorsen,et al.  Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction , 2016, BMC Cardiovascular Disorders.

[11]  E. Peterson,et al.  Effectiveness of cardiac rehabilitation among older patients after acute myocardial infarction. , 2015, American heart journal.

[12]  D. Panagiotakos,et al.  Lower Financial Status and Adherence to Medication Determines 10-Year (2004-2014) All-Cause Mortality and Risk for Acute Coronary Syndrome Incidence Among Cardiac Patients: the GREECS Study. , 2015, Current vascular pharmacology.

[13]  T. Henry,et al.  Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study. , 2015, American heart journal.

[14]  E. Peterson,et al.  Persistence of evidence-based medication use after discharge from academic versus nonacademic hospitals among patients with non-ST-segment elevation myocardial infarction. , 2014, The American journal of cardiology.

[15]  Deepak L. Bhatt,et al.  Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis. , 2013, The American journal of medicine.

[16]  L. Wallentin,et al.  Similar outcome with an invasive strategy in men and women with non-ST-elevation acute coronary syndromes: from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). , 2011, European heart journal.

[17]  K. Bestehorn,et al.  Guideline-recommended secondary prevention drug therapy after acute myocardial infarction: predictors and outcomes of nonadherence , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[18]  E. Hannan,et al.  Temporal Trends in the Use of Percutaneous Coronary Intervention and Coronary Artery Bypass Surgery in New York State and Ontario , 2010, Circulation.

[19]  L. Newby,et al.  Comparative trends in guidelines adherence among patients with non-ST-segment elevation acute coronary syndromes treated with invasive versus conservative management strategies: Results from the CRUSADE quality improvement initiative. , 2009, American heart journal.

[20]  J. Ornato,et al.  Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. , 2008, American heart journal.

[21]  R. Califf,et al.  Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease. , 2008, JACC. Cardiovascular interventions.

[22]  P Michael Ho,et al.  Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. , 2008, American heart journal.

[23]  Ping Li,et al.  Prevalence, Predictors, and Outcomes of Primary Nonadherence After Acute Myocardial Infarction , 2008, Circulation.

[24]  A. Yan,et al.  Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome. , 2007, American heart journal.

[25]  D. Alter,et al.  Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. , 2007, JAMA.

[26]  Therese A. Stukel,et al.  Long-term Outcomes of Regional Variations in Intensity of Invasive vs Medical Management of Medicare Patients With Acute Myocardial Infarction , 2005 .

[27]  Deepak L. Bhatt,et al.  Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: Results From the CRUSADE Quality Improvement Initiative , 2004 .

[28]  T. Brennan,et al.  Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes. , 2014, American heart journal.

[29]  K. Alexander,et al.  Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudy. , 2010, Circulation.